Skip to main content
Top
Published in: AIDS and Behavior 9/2019

01-09-2019 | Human Immunodeficiency Virus | Original Paper

“You Take Medications, You Live Normally”: The Role of Antiretroviral Therapy in Mitigating Men’s Perceived Threats of HIV in Côte d’Ivoire

Authors: Zoé Mistrale Hendrickson, Danielle A. Naugle, Natalie Tibbels, Abdul Dosso, Lynn M. Van Lith, Elizabeth C. Mallalieu, Diarra Kamara, Patricia Dailly-Ajavon, Adama Cisse, Kim Seifert Ahanda, Sereen Thaddeus, Stella Babalola, Christopher J. Hoffmann

Published in: AIDS and Behavior | Issue 9/2019

Login to get access

Abstract

Men diagnosed with HIV face gender-related barriers to initiating and adhering to antiretroviral therapy (ART). This qualitative study (73 in-depth interviews; 28 focus group discussions), conducted with men in three urban sites in Côte d’Ivoire in 2016, examined perceptions of ART, including benefits and challenges, to explore how ART mitigates HIV’s threats to men’s sexuality, economic success, family roles, social status, and health. Participants perceived that adhering to ART would reduce risk of transmitting HIV to others, minimize job loss and lost productivity, and help maintain men’s roles as decision makers and providers. ART adherence was thought to help reduce the threat of HIV-related stigma, despite concerns about unintentional disclosure. While ART was perceived to improve health directly, it restricted men’s schedules. Side effects were also a major challenge. Social and behavior change approaches building on these insights may improve male engagement across the HIV care continuum.
Literature
1.
go back to reference UNAIDS. 90-90-90: an ambitious treatment target to help end the AIDS epidemic. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS), 2014 Contract No.: JC2684; 2014. UNAIDS. 90-90-90: an ambitious treatment target to help end the AIDS epidemic. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS), 2014 Contract No.: JC2684; 2014.
2.
go back to reference WHO. Progress report 2016: prevent HIV, test and treat all. WHO support for country impact. WHO/HIV/2016.24. Geneva, Switzerland: WHO; 2016. WHO. Progress report 2016: prevent HIV, test and treat all. WHO support for country impact. WHO/HIV/2016.24. Geneva, Switzerland: WHO; 2016.
3.
go back to reference Shah M, Risher K, Berry SA, Dowdy DW. The epidemiologic and economic impact of improving HIV testing, linkage, and retention in care in the United States. Clin Infect Dis. 2015;62(2):220–9.CrossRef Shah M, Risher K, Berry SA, Dowdy DW. The epidemiologic and economic impact of improving HIV testing, linkage, and retention in care in the United States. Clin Infect Dis. 2015;62(2):220–9.CrossRef
4.
go back to reference Adams AK, Zamberia AM. “I will take ARVs once my body deteriorates”: an analysis of Swazi men’s perceptions and acceptability of Test and Start. Afr J AIDS Res. 2017;16(4):295–303.CrossRef Adams AK, Zamberia AM. “I will take ARVs once my body deteriorates”: an analysis of Swazi men’s perceptions and acceptability of Test and Start. Afr J AIDS Res. 2017;16(4):295–303.CrossRef
5.
go back to reference WHO. Treat all: policy adoption and implementation status in countries. WHO/HIV/2017.58. Geneva, Switzerland: WHO; 2017. WHO. Treat all: policy adoption and implementation status in countries. WHO/HIV/2017.58. Geneva, Switzerland: WHO; 2017.
7.
go back to reference Maheu-Giroux M, Vesga JF, Diabaté S, Alary M, Baral S, Diouf D, et al. Population-level impact of an accelerated HIV response plan to reach the UNAIDS 90-90-90 target in Côte d’Ivoire: insights from mathematical modeling. PLoS Med. 2017;14(6):e1002321.CrossRef Maheu-Giroux M, Vesga JF, Diabaté S, Alary M, Baral S, Diouf D, et al. Population-level impact of an accelerated HIV response plan to reach the UNAIDS 90-90-90 target in Côte d’Ivoire: insights from mathematical modeling. PLoS Med. 2017;14(6):e1002321.CrossRef
8.
go back to reference Siu GE, Wight D, Seeley J. How a masculine work ethic and economic circumstances affect uptake of HIV treatment: experiences of men from an artisanal gold mining community in rural eastern Uganda. J Int AIDS Soc. 2012;15(Suppl 1):1–9.PubMed Siu GE, Wight D, Seeley J. How a masculine work ethic and economic circumstances affect uptake of HIV treatment: experiences of men from an artisanal gold mining community in rural eastern Uganda. J Int AIDS Soc. 2012;15(Suppl 1):1–9.PubMed
9.
go back to reference Nyamhanga TM, Muhondwa EPY, Shayo R. Masculine attitudes of superiority deter men from accessing antiretroviral therapy in Dar es Salaam, Tanzania. Glob Health Action. 2013;6(1):21812.CrossRef Nyamhanga TM, Muhondwa EPY, Shayo R. Masculine attitudes of superiority deter men from accessing antiretroviral therapy in Dar es Salaam, Tanzania. Glob Health Action. 2013;6(1):21812.CrossRef
10.
go back to reference Chikovore J, Gillespie N, McGrath N, Orne-Gliemann J, Zuma T, Group A 12249 TS. Men, masculinity, and engagement with treatment as prevention in KwaZulu-Natal, South Africa. AIDS Care. 2016;28(sup3):74–82.CrossRef Chikovore J, Gillespie N, McGrath N, Orne-Gliemann J, Zuma T, Group A 12249 TS. Men, masculinity, and engagement with treatment as prevention in KwaZulu-Natal, South Africa. AIDS Care. 2016;28(sup3):74–82.CrossRef
11.
go back to reference Shand T, Thomson-de Boor H, van den Berg W, Peacock D, Pascoe L. The HIV blind spot: men and HIV testing, treatment and care in sub-Saharan Africa. IDS Bull. 2014;45(1):53–60.CrossRef Shand T, Thomson-de Boor H, van den Berg W, Peacock D, Pascoe L. The HIV blind spot: men and HIV testing, treatment and care in sub-Saharan Africa. IDS Bull. 2014;45(1):53–60.CrossRef
12.
go back to reference Parrott FR, Mwafulirwa C, Ngwira B, Nkhwazi S, Floyd S, Houben RMGJ, et al. Combining qualitative and quantitative evidence to determine factors leading to late presentation for antiretroviral therapy in Malawi. PLoS ONE. 2011;6(11):e27917.CrossRef Parrott FR, Mwafulirwa C, Ngwira B, Nkhwazi S, Floyd S, Houben RMGJ, et al. Combining qualitative and quantitative evidence to determine factors leading to late presentation for antiretroviral therapy in Malawi. PLoS ONE. 2011;6(11):e27917.CrossRef
13.
go back to reference Gari S, Martin-Hilber A, Malungo JRS, Musheke M, Merten S. Sex differentials in the uptake of antiretroviral treatment in Zambia. AIDS Care. 2014;26(10):1258–62.CrossRef Gari S, Martin-Hilber A, Malungo JRS, Musheke M, Merten S. Sex differentials in the uptake of antiretroviral treatment in Zambia. AIDS Care. 2014;26(10):1258–62.CrossRef
14.
go back to reference Druyts E, Dybul M, Kanters S, Nachega J, Birungi J, Ford N, et al. Male sex and the risk of mortality among individuals enrolled in antiretroviral therapy programs in Africa: a systematic review and meta-analysis. AIDS. 2013;27(3):417–25.CrossRef Druyts E, Dybul M, Kanters S, Nachega J, Birungi J, Ford N, et al. Male sex and the risk of mortality among individuals enrolled in antiretroviral therapy programs in Africa: a systematic review and meta-analysis. AIDS. 2013;27(3):417–25.CrossRef
15.
go back to reference Kagee A, Remien RH, Berkman A, Hoffman S, Campos L, Swartz L. Structural barriers to ART adherence in Southern Africa: challenges and potential ways forward. Glob Public Health. 2011;6(1):83–97.CrossRef Kagee A, Remien RH, Berkman A, Hoffman S, Campos L, Swartz L. Structural barriers to ART adherence in Southern Africa: challenges and potential ways forward. Glob Public Health. 2011;6(1):83–97.CrossRef
16.
go back to reference Cornell M, Schomaker M, Garone DB, Giddy J, Hoffmann CJ, Lessells R, et al. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study. PLoS Med. 2012;9(9):e1001304.CrossRef Cornell M, Schomaker M, Garone DB, Giddy J, Hoffmann CJ, Lessells R, et al. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study. PLoS Med. 2012;9(9):e1001304.CrossRef
17.
go back to reference Dovel K, Yeatman S, Watkins S, Poulin M. Men’s heightened risk of AIDS-related death: the legacy of gendered HIV testing and treatment strategies. AIDS. 2015;29(10):1123–5.CrossRef Dovel K, Yeatman S, Watkins S, Poulin M. Men’s heightened risk of AIDS-related death: the legacy of gendered HIV testing and treatment strategies. AIDS. 2015;29(10):1123–5.CrossRef
18.
go back to reference Hodgson I, Plummer ML, Konopka SN, Colvin CJ, Jonas E, Albertini J, et al. A systematic review of individual and contextual factors affecting ART initiation, adherence, and retention for HIV-infected pregnant and postpartum women. PLoS ONE. 2014;9(11):e111421.CrossRef Hodgson I, Plummer ML, Konopka SN, Colvin CJ, Jonas E, Albertini J, et al. A systematic review of individual and contextual factors affecting ART initiation, adherence, and retention for HIV-infected pregnant and postpartum women. PLoS ONE. 2014;9(11):e111421.CrossRef
19.
go back to reference Holtzman CW, Brady KA, Yehia BR. Retention in care and medication adherence: current challenges to antiretroviral therapy success. Drugs. 2015;75(5):445–54.CrossRef Holtzman CW, Brady KA, Yehia BR. Retention in care and medication adherence: current challenges to antiretroviral therapy success. Drugs. 2015;75(5):445–54.CrossRef
20.
go back to reference Hoffmann CJ, Mabuto T, McCarthy K, Maulsby C, Holtgrave DR. A framework to inform strategies to improve the HIV care continuum in low-and middle-income countries. AIDS Educ Prev. 2016;28(4):351–64.CrossRef Hoffmann CJ, Mabuto T, McCarthy K, Maulsby C, Holtgrave DR. A framework to inform strategies to improve the HIV care continuum in low-and middle-income countries. AIDS Educ Prev. 2016;28(4):351–64.CrossRef
21.
go back to reference Govindasamy D, van Schaik N, Kranzer K, Wood R, Mathews C, Bekker L-G. Linkage to HIV care from a mobile testing unit in South Africa by different CD4 count strata. J Acquir Immune Defic Syndr. 2011;58(3):344–52.CrossRef Govindasamy D, van Schaik N, Kranzer K, Wood R, Mathews C, Bekker L-G. Linkage to HIV care from a mobile testing unit in South Africa by different CD4 count strata. J Acquir Immune Defic Syndr. 2011;58(3):344–52.CrossRef
22.
go back to reference Johnson LF. Access to antiretroviral treatment in South Africa, 2004–2011. South Afr J HIV Med. 2012;13(1):22–7.CrossRef Johnson LF. Access to antiretroviral treatment in South Africa, 2004–2011. South Afr J HIV Med. 2012;13(1):22–7.CrossRef
23.
go back to reference Kranzer K, Zeinecker J, Ginsberg P, Orrell C, Kalawe NN, Lawn SD, et al. Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa. PLoS ONE. 2010;5(11):e13801.CrossRef Kranzer K, Zeinecker J, Ginsberg P, Orrell C, Kalawe NN, Lawn SD, et al. Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa. PLoS ONE. 2010;5(11):e13801.CrossRef
24.
go back to reference Musheke M, Ntalasha H, Gari S, McKenzie O, Bond V, Martin-Hilber A, et al. A systematic review of qualitative findings on factors enabling and deterring uptake of HIV testing in sub-Saharan Africa. BMC Public Health. 2013;13(220):1–16. Musheke M, Ntalasha H, Gari S, McKenzie O, Bond V, Martin-Hilber A, et al. A systematic review of qualitative findings on factors enabling and deterring uptake of HIV testing in sub-Saharan Africa. BMC Public Health. 2013;13(220):1–16.
25.
go back to reference Siu GE, Seeley J, Wight D. Dividuality, masculine respectability and reputation: how masculinity affects men’s uptake of HIV treatment in rural eastern Uganda. Soc Sci Med. 2013;89:45–52.CrossRef Siu GE, Seeley J, Wight D. Dividuality, masculine respectability and reputation: how masculinity affects men’s uptake of HIV treatment in rural eastern Uganda. Soc Sci Med. 2013;89:45–52.CrossRef
26.
go back to reference Camlin CS, Ssemmondo E, Chamie G, El Ayadi AM, Kwarisiima D, Sang N, et al. Men “missing” from population-based HIV testing: insights from qualitative research. AIDS Care. 2016;28(sup3):67–73.CrossRef Camlin CS, Ssemmondo E, Chamie G, El Ayadi AM, Kwarisiima D, Sang N, et al. Men “missing” from population-based HIV testing: insights from qualitative research. AIDS Care. 2016;28(sup3):67–73.CrossRef
27.
go back to reference Merten S, Kenter E, McKenzie O, Musheke M, Ntalasha H, Martin-Hilber A. Patient-reported barriers and drivers of adherence to antiretrovirals in sub-Saharan Africa: a meta-ethnography. Trop Med Int Health. 2010;15(s1):16–33.CrossRef Merten S, Kenter E, McKenzie O, Musheke M, Ntalasha H, Martin-Hilber A. Patient-reported barriers and drivers of adherence to antiretrovirals in sub-Saharan Africa: a meta-ethnography. Trop Med Int Health. 2010;15(s1):16–33.CrossRef
28.
go back to reference Gottert A, Barrington C, McNaughton-Reyes HL, Maman S, MacPhail C, Lippman SA, et al. Gender norms, gender role conflict/stress and HIV risk behaviors among men in Mpumalanga, South Africa. AIDS Behav. 2017;22(6):1858–69.CrossRef Gottert A, Barrington C, McNaughton-Reyes HL, Maman S, MacPhail C, Lippman SA, et al. Gender norms, gender role conflict/stress and HIV risk behaviors among men in Mpumalanga, South Africa. AIDS Behav. 2017;22(6):1858–69.CrossRef
29.
go back to reference Morrell R, Jewkes RK, Lindegger G, Hamlall V. Hegemonic masculinity: reviewing the gendered analysis of men’s power in South Africa. S Afr Rev Sociol. 2013;44(1):3–21.CrossRef Morrell R, Jewkes RK, Lindegger G, Hamlall V. Hegemonic masculinity: reviewing the gendered analysis of men’s power in South Africa. S Afr Rev Sociol. 2013;44(1):3–21.CrossRef
30.
go back to reference Hanass-Hancock J, Myezwa H, Nixon SA, Gibbs A. “When I was no longer able to see and walk, that is when I was affected most”: experiences of disability in people living with HIV in South Africa. Disabil Rehabil. 2015;37(22):2051–60.CrossRef Hanass-Hancock J, Myezwa H, Nixon SA, Gibbs A. “When I was no longer able to see and walk, that is when I was affected most”: experiences of disability in people living with HIV in South Africa. Disabil Rehabil. 2015;37(22):2051–60.CrossRef
31.
go back to reference Mburu G, Ram M, Siu G, Bitira D, Skovdal M, Holland P. Intersectionality of HIV stigma and masculinity in eastern Uganda: implications for involving men in HIV programmes. BMC Public Health. 2014;14(1):1061.CrossRef Mburu G, Ram M, Siu G, Bitira D, Skovdal M, Holland P. Intersectionality of HIV stigma and masculinity in eastern Uganda: implications for involving men in HIV programmes. BMC Public Health. 2014;14(1):1061.CrossRef
32.
go back to reference Sikweyiya YM, Jewkes R, Dunkle K. Impact of HIV on and the constructions of masculinities among HIV-positive men in South Africa: implications for secondary prevention programs. Glob Health Action. 2014;7(1):1–13.CrossRef Sikweyiya YM, Jewkes R, Dunkle K. Impact of HIV on and the constructions of masculinities among HIV-positive men in South Africa: implications for secondary prevention programs. Glob Health Action. 2014;7(1):1–13.CrossRef
33.
go back to reference Naugle DA, Tibbels N, Hendrickson ZM, Dosso A, Van Lith L, Mallalieu EC, et al. Bringing fear into focus: the intersections of HIV and masculine gender norms in Côte d’Ivoire. 2019. Naugle DA, Tibbels N, Hendrickson ZM, Dosso A, Van Lith L, Mallalieu EC, et al. Bringing fear into focus: the intersections of HIV and masculine gender norms in Côte d’Ivoire. 2019.
39.
go back to reference The Editors of Encyclopaedia Britannica. Abidjan. In: Encyclopaedia Britannica. Encyclopaedia Britannica, Inc.: 2015. p. 1. The Editors of Encyclopaedia Britannica. Abidjan. In: Encyclopaedia Britannica. Encyclopaedia Britannica, Inc.: 2015. p. 1.
43.
go back to reference ATLAS/ti. ATLAS/ti. Version 1.0.51. (Computer sofware for Mac). Scientific Sofware Development, Berlin; 2015. ATLAS/ti. ATLAS/ti. Version 1.0.51. (Computer sofware for Mac). Scientific Sofware Development, Berlin; 2015.
44.
go back to reference Nyamhanga TM, Muhondwa EP, Shayo R. Masculine attitudes of superiority deter men from accessing antiretroviral therapy in Dar es Salaam. Tanzania. Glob Heal Action. 2013;6:21812.CrossRef Nyamhanga TM, Muhondwa EP, Shayo R. Masculine attitudes of superiority deter men from accessing antiretroviral therapy in Dar es Salaam. Tanzania. Glob Heal Action. 2013;6:21812.CrossRef
45.
go back to reference Fleming PJ, Barrington C, Powell W, Gottert A, Lerebours L, Donastorg Y, et al. The association between men’s concern about demonstrating masculine characteristics and their sexual risk behaviors: findings from the dominican republic. Arch Sex Behav. 2018;47(2):507–15.CrossRef Fleming PJ, Barrington C, Powell W, Gottert A, Lerebours L, Donastorg Y, et al. The association between men’s concern about demonstrating masculine characteristics and their sexual risk behaviors: findings from the dominican republic. Arch Sex Behav. 2018;47(2):507–15.CrossRef
46.
go back to reference Aho J, Hakim A, Vuylsteke B, Semde G, Gbais HG, Diarrassouba M, et al. Exploring risk behaviors and vulnerability for HIV among men who have sex with men in Abidjan, Cote d′ Ivoire: poor knowledge, homophobia and sexual violence. PLoS ONE. 2014;9(6):e99591.CrossRef Aho J, Hakim A, Vuylsteke B, Semde G, Gbais HG, Diarrassouba M, et al. Exploring risk behaviors and vulnerability for HIV among men who have sex with men in Abidjan, Cote d′ Ivoire: poor knowledge, homophobia and sexual violence. PLoS ONE. 2014;9(6):e99591.CrossRef
Metadata
Title
“You Take Medications, You Live Normally”: The Role of Antiretroviral Therapy in Mitigating Men’s Perceived Threats of HIV in Côte d’Ivoire
Authors
Zoé Mistrale Hendrickson
Danielle A. Naugle
Natalie Tibbels
Abdul Dosso
Lynn M. Van Lith
Elizabeth C. Mallalieu
Diarra Kamara
Patricia Dailly-Ajavon
Adama Cisse
Kim Seifert Ahanda
Sereen Thaddeus
Stella Babalola
Christopher J. Hoffmann
Publication date
01-09-2019
Publisher
Springer US
Published in
AIDS and Behavior / Issue 9/2019
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-019-02614-5

Other articles of this Issue 9/2019

AIDS and Behavior 9/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.